000150:KRXDoosan Corporation Analysis
Data as of 2026-05-28 - not real-time
₩1,660,000.00
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Doosan Corp (000150.KS) is trading at roughly 1.66 million KRW, which is more than double the DCF‑derived fair value of 757 k KRW and carries a forward P/E of 39.6× versus an industry average of 30.1×. The stock sits above its 20‑day, 50‑day and 200‑day moving averages, confirming a bullish price bias, yet the MACD histogram is negative and the MACD line trails its signal, hinting at short‑term momentum weakness. Volume is on an upward trend and the RSI sits at a neutral 56, suggesting the rally has room to breathe but may encounter resistance near the 1.90 M ceiling.
Fundamentally, Doosan delivers robust top‑line growth of 17.7% YoY and a solid operating cash flow of 1.11 trillion KRW, but profit margins are thin (net margin 79.5%. The dividend yield is a modest 0.29% backed by a lofty 79% payout ratio, raising sustainability concerns given limited earnings. Elevated volatility (65% 30‑day) and a beta of 2.34 amplify market risk, while the conglomerate’s global footprint spreads geographic exposure across Korea, the US, Europe and the Middle East.
Fundamentally, Doosan delivers robust top‑line growth of 17.7% YoY and a solid operating cash flow of 1.11 trillion KRW, but profit margins are thin (net margin 79.5%. The dividend yield is a modest 0.29% backed by a lofty 79% payout ratio, raising sustainability concerns given limited earnings. Elevated volatility (65% 30‑day) and a beta of 2.34 amplify market risk, while the conglomerate’s global footprint spreads geographic exposure across Korea, the US, Europe and the Middle East.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price above key moving averages but MACD bearish
- High valuation relative to DCF and peers
- Increasing volume supports potential upside
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Strong revenue growth and cash flow generation
- Elevated debt levels and thin profit margins
- Continued overvaluation may limit upside
Long Term
> 3 yearsCautious
Model confidence: 6/10
Key Factors
- Persistently high valuation versus fundamentals
- Debt burden and low dividend sustainability
- High beta and volatility increase downside risk
Key Metrics & Analysis
Financial Health
Revenue Growth17.70%
Profit Margin0.44%
P/E Ratio39.6
ROE2.69%
ROA2.19%
Debt/Equity79.54
Op. Cash Flow₩1113.9B
Free Cash Flow₩660.2B
Industry P/E30.1
Technical Analysis
TrendBullish
RSI55.9
Support₩1,401,000.00
Resistance₩1,900,000.00
MA 20₩1,655,650.00
MA 50₩1,408,240.00
MA 200₩948,345.00
MACDBearish
VolumeIncreasing
Fear & Greed Index91.52
Valuation
Fair Value₩757,237.98
Target Price₩2,085,000.00
Upside/Downside25.60%
GradeOvervalued
TypeGrowth
Dividend Yield0.29%
Risk Assessment
Beta2.34
Volatility65.04%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.